Anti-Rheumatic Rx
HCQ and QTc in RA and SLE Patients: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract #0431 presented at the 2020 ACR annual meeting.
HCQ and QTc Prolongation: Dr David Liew
Dr. David Liew reviews abstracts #0431 presented at the ACR 2020 annual meeting - and shares the results of the Twitter poll he conducted asking when prescribing HCQ, is an EKG routinely ordered either before or doing.
Methotrexate Induced Liver Fibrosis: Dr. Sheila Reyes
Dr. Sheila Reyes discusses abstract #0205 presented Friday at the 2020 ACR annual meeting.
Does Hydroxychloroquine Hurt the Heart? Dr. Jonathan Kay
Boston-based rheumatologist Dr. Jonathan Kay examines an ACR 2020 study (abstract #0431) looking at whether hydroxychloroquine use has injured patients' hearts.
Methotrexate and Nonalcoholic Fatty Liver Disease: Dr Eric Dein
Dr. Eric Dein discusses the findings of abstract #0181 at the ACR 2020 annual meeting.
HCQ Not Associated with QTc Length in SLE and RA Patients: Dr. Janet Pope
Dr. Janet Pope discusses abstract #0431 presented Friday at the ACR 2020 virtual meeting.
Global Rheumatology Alliance Panel
Dr. Kathryn Dao interviews Dr. Jinoos Yazdany, Dr. Philip Robinson and Dr. Jean Liew with the Global Rheumatology Alliance.
The RECIPE Study - MMF in Refractory Gout: Dr. Jack Cush
Dr. Jack Cush previews the RECIPE study, wherein MMF is used to blunt the immunogenicity of pegloticase (abstract #0952 presented at the ACR 2020 annual meeting).
Antimalarials in Pre COVID-19 Era: Dr. Janet Pope
Dr. Pope discusses abstract #0002 presented at the #ACR20 annual meeting.
QD Clinic - Running out of Options
Difficult RA with Serious Infections and Limited options
Poster Hall